Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPRI: Ciclosporin in STEMI Reperfusion Injury
NCT02390674Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Mar 2015
- Primary completion
- Apr 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in myocardial reperfusion injury, sponsored by Newcastle Hospitals NHS Foundation Trust. Started Mar 2015; status: completed.
02
Drugs
cyclosporine
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT02390674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390674.